Correlation Between XTL Biopharmaceutica and Intergama

Can any of the company-specific risk be diversified away by investing in both XTL Biopharmaceutica and Intergama at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining XTL Biopharmaceutica and Intergama into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between XTL Biopharmaceuticals and Intergama, you can compare the effects of market volatilities on XTL Biopharmaceutica and Intergama and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in XTL Biopharmaceutica with a short position of Intergama. Check out your portfolio center. Please also check ongoing floating volatility patterns of XTL Biopharmaceutica and Intergama.

Diversification Opportunities for XTL Biopharmaceutica and Intergama

-0.7

Correlation Coefficient

XTL Biopharmaceutica  Intergama

Excellent diversification

The 3 months correlation between XTL and Intergama is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding XTL Biopharmaceuticals and Intergama in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intergama and XTL Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on XTL Biopharmaceuticals are associated (or correlated) with Intergama. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intergama has no effect on the direction of XTL Biopharmaceutica i.e., XTL Biopharmaceutica and Intergama go up and down completely randomly.

Pair Corralation between XTL Biopharmaceutica and Intergama

Assuming the 90 days trading horizon XTL Biopharmaceuticals is expected to under-perform the Intergama. In addition to that, XTL Biopharmaceutica is 2.21 times more volatile than Intergama. It trades about -0.08 of its total potential returns per unit of risk. Intergama is currently generating about 0.06 per unit of volatility. If you would invest  635,000  in Intergama on September 30, 2024 and sell it today you would earn a total of  45,000  from holding Intergama or generate 7.09% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

XTL Biopharmaceuticals  vs.  Intergama

XTL Biopharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days XTL Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Intergama

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Intergama are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Intergama may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with XTL Biopharmaceutica and Intergama

The main advantage of trading using opposite XTL Biopharmaceutica and Intergama positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if XTL Biopharmaceutica position performs unexpectedly, Intergama can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intergama will offset losses from the drop in Intergama's long position.

The idea behind XTL Biopharmaceuticals and Intergama pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.